Comments
Medivation prostate cancer drug well-tolerated in trial
01.02.2012. | (Reuters) - Medivation Inc's experimental prostate cancer pill caused fewer serious side effects in clinical trial patients than a placebo treatment, according to full results from a pivotal study announced on Tuesday....
